| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.006 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |